Shao-Jing Wang

1PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 16, 2024
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel.

Shao-Jing Wang, Hsin-Hua Chen, Lou Sun

Pageof 1

Frequent Collaborators

1 joint publications

Hsin-Hua Chen

1 joint publications

Lou Sun

1 joint publications

Shih-Tien Hsu

1 joint publications

Chien-Hsing Lu